Mission Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,800
Closed -$1.84M 568
2026
Q1
$1.66M Sell
1,800
-200
-10% -$203K 0.03% 243
2025
Q4
$2.15M Hold
2,000
0.04% 211
2025
Q3
$1.53M Buy
+2,000
New +$1.49M 0.03% 253
2025
Q2
Hold
0
239
2025
Q1
Hold
0
350
2024
Q4
Hold
0
338

Other funds holding LLY

Mission Wealth Management's LLY Position: Q2 2026 in Review

Mission Wealth Management increased its Eli Lilly (LLY) stake by 72% in Q2 2026, buying an estimated $11M and bringing the position to 25,625 shares worth $30.7M. The position accounts for 0.38% of the portfolio, ranked #44.

Mission Wealth Management first reported a position in LLY in Q3 2015 and has held it in 44 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mission Wealth Management held 25,625 shares of Eli Lilly worth $30.7M as of Q2 2026.
  • Mission Wealth Management bought 10,718 Eli Lilly shares in Q2 2026, an estimated $11M.
  • Eli Lilly made up 0.38% of Mission Wealth Management's portfolio in Q2 2026, its #44 holding.
  • Mission Wealth Management first reported a position in Eli Lilly in Q3 2015 and has held it in 44 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.